首页|司美格鲁肽致荨麻疹伴血管神经性水肿综合征一例

司美格鲁肽致荨麻疹伴血管神经性水肿综合征一例

扫码查看
本文报道1例55岁女性患者,在使用司美格鲁肽第8天出现全身瘙痒和面部水肿,尤以嘴唇和眼睑水肿严重,诊断为荨麻疹伴血管神经性水肿,结合病史及用药史,考虑为司美格鲁肽引起的不良反应。停用司美格鲁肽并予以对症治疗后,患者皮疹和水肿消退。司美格鲁肽引起的血管神经性水肿为偶见不良反应,但后果严重,警示医务人员重点关注该不良反应的发生,用药时详细询问患者过敏史,并做好用药教育。
Semaglutide-induced acute urticaria with angioneurotic edema:a case report
This article reported a case of a 55-year-old female patient who developed generalized itching and facial ede-ma on the 8th day after receiving semaglutide,especially severe edema of the lips and eyelids,and she was diagnosed as urti-caria with angioneurotic edema.Combined with the history of the disease and the history of medication use,the patient was considered to have an adverse reaction induced by semaglutide.The patient's rash and edema subsided after stopping semaglu-tide and symptomatic treatment.Angioneurotic edema caused by semaglutide is an occasional adverse reaction,but the conse-quences are serious.Therefore the medical professionals are suggested to pay attention to the occurrence of this kind of adverse reaction,and to ask the patients about their allergy history and provide drug education.

semaglutideurticaangioneurotic edemaadverse reactions

任桂玲、徐磊、苏长海、杨俊丽

展开 >

鄂尔多斯市中心医院 药剂科,内蒙古 鄂尔多斯 017000

司美格鲁肽 荨麻疹 血管神经性水肿 不良反应

鄂尔多斯市财政资助医学重点学科建设

鄂卫健发[2020]230号

2024

临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
年,卷(期):2024.22(6)
  • 3